Nuvation Bio to Report First Quarter 2026 Financial Results and Provide Business Update on May 4, 2026

B NEW YORK, April 20, 2026 /PRNewswire/ — Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges…
posteditor
posteditor
Articles: 21727

Other News